Cytokinetics | CYTK - Gross Profit On Sales

Stock Price
66.81
Daily Change
1.33 2.03%
Monthly
7.03%
Yearly
79.02%
Q2 Forecast
64.72

Cytokinetics reported $17.76M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 257.76M 778K Dec/2025
Amgen USD 6.48B 307M Sep/2025
Arca Biopharma 0 0 Mar/2025
Bayer EUR 5.35B 1.02B Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cytokinetics USD 17.76M 15.82M Dec/2025
Eisai JPY 168.85B 17.02B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Exelixis USD 572.18M 7M Dec/2025
Geron USD 46.71M 525K Dec/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Ligand Pharmaceuticals USD 155.28M 82.42M Sep/2025
Merck USD 13.42B 431M Sep/2025
Novartis USD 10.25B 570M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025